FIRM FIXED PRICENO SET ASIDE USED.

THE UNIVERSITY OF CHICAGO MEDICAL CENTER - [24-014184] THE LAB REQUIRES MYELOID MALIGNANCY SEQUENCING PANEL IN ORDER TO THIS TESTING IS REQUIRED TO MAKE CLINICAL DECISIONS FOR PATIENTS SEEN IN OUR CLINIC, RELATES TO CHOICE OF BONE MARROW TRANSPLANT DONOR OR TREATMENT WITH IMMUNOSUPPRESSION. P

PIID: 75N92024P00245

Signed Date: Jan 23, 2026Effective Date: Jul 11, 2024End Date: Closed on Jan 23, 2026

Key Details

Dollars Obligated

$25,000

Base & All Options

$12,640

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

622110 - GENERAL MEDICAL AND SURGICAL HOSPITALS

Product Service Code

Q301 - REFERENCE LABORATORY TESTING

Extent Competed

NOT COMPETED

Number of Offers

Place of Performance

CHICAGO, IL, 606371089, CD-IL-07

Description

[24-014184] THE LAB REQUIRES MYELOID MALIGNANCY SEQUENCING PANEL IN ORDER TO THIS TESTING IS REQUIRED TO MAKE CLINICAL DECISIONS FOR PATIENTS SEEN IN OUR CLINIC, RELATES TO CHOICE OF BONE MARROW TRANSPLANT DONOR OR TREATMENT WITH IMMUNOSUPPRESSION. P